Literature DB >> 1550412

Association of Wegener's granulomatosis with HLA antigens and other genetic markers.

S S Papiha1, G E Murty, A Ad'Hia, B T Mains, M Venning.   

Abstract

The frequencies of the HLA-A, B, C, DR, DQ antigens and of several other genetic markers in biopsy proved and well characterised patients with Wegener's granulomatosis were compared with control frequencies of the region. A highly significant increase in HLA-DR1 was found. The percentage combined frequency of DR1-DQw1 was significantly higher in patients than in the controls. Interestingly, association with the red cell enzyme GLOI and complement locus C4B was also seen. As both of these markers are either linked or within the major histocompatibility complex region (MHC) this is further evidence for the involvement of chromosome 6 in the pathogenesis of Wegener's granulomatosis. To understand the pathology of the disease fully molecular genetic studies of the MHC region are warranted.

Entities:  

Mesh：

Substances：

Year:  1992        PMID： 1550412      PMCID： PMC1005667          DOI： 10.1136/ard.51.2.246

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN： 0003-4967            Impact factor:   19.103


  13 in total

1.  Wegener's granulomatosis. Long-term followup of patients treated with cyclophosphamide.

Authors:  M J Reza; L Dornfeld; L S Goldberg; R Bluestone; C M Pearson
Journal:  Arthritis Rheum       Date:  1975 Sep-Oct

2.  Wegener's granulomatosis in a family. A short report.

Authors:  B B Knudsen; T Joergensen; B Munch-Jensen
Journal:  Scand J Rheumatol       Date:  1988       Impact factor: 3.641

Review 3.  The concept of limited forms of Wegener's granulomatosis.

Authors:  S M Cassan; D T Coles; E G Harrison
Journal:  Am J Med       Date:  1970-09       Impact factor: 4.965

4.  HLA antigen frequencies in systemic vasculitis: increase in HLA-DR2 in Wegener's granulomatosis.

Authors:  K B Elkon; D C Sutherland; A J Rees; G R Hughes; J R Batchelor
Journal:  Arthritis Rheum       Date:  1983-01

5.  Association of HLA and other genetic markers in South Indian patients with pulmonary tuberculosis.

Authors:  S S Papiha; B N Singh; J S Lanchbury; D F Roberts; C E Parsad; J Wentzel; K J Murty
Journal:  Tubercle       Date:  1987-09

6.  HLA-A antigens of patients with Wegener's granulomatosis.

Authors:  C V Strimlan; H F Taswell; F Kueppers; R A DeRemee; T J McDonald
Journal:  Tissue Antigens       Date:  1978-02

7.  Raised serum immunoglobulin E in Wegener's granulomatosis.

Authors:  D L Conn; G J Gleich; R A DeRemee; T J McDonald
Journal:  Ann Rheum Dis       Date:  1976-08       Impact factor: 19.103

8.  Wegener's granulomatosis - clinical-pathologic correlations and long-term course.

Authors:  G B Appel; B Gee; M Kashgarian; J P Hayslett
Journal:  Am J Kidney Dis       Date:  1981-07       Impact factor: 8.860

Review 9.  Wegener's granulomatosis: prospective clinical and therapeutic experience with 85 patients for 21 years.

Authors:  A S Fauci; B F Haynes; P Katz; S M Wolff
Journal:  Ann Intern Med       Date:  1983-01       Impact factor: 25.391

10.  Autoantibodies against neutrophils and monocytes: tool for diagnosis and marker of disease activity in Wegener's granulomatosis.

Authors:  F J van der Woude; N Rasmussen; S Lobatto; A Wiik; H Permin; L A van Es; M van der Giessen; G K van der Hem; T H The
Journal:  Lancet       Date:  1985-02-23       Impact factor: 79.321
View more
  15 in total

1.  Immunogenetic risk factors for anti-neutrophil cytoplasmic antibody (ANCA)-associated systemic vasculitis.

Authors:  M Gencik; S Borgmann; R Zahn; E Albert; T Sitter; J T Epplen; H Fricke
Journal:  Clin Exp Immunol       Date:  1999-08       Impact factor: 4.330

Review 2.  Cellular aspects of vasculitis--T cell-mediated aspects.

Authors:  M E Griffith; C D Pusey
Journal:  Springer Semin Immunopathol       Date:  2001

3.  ANCA patients have T cells responsive to complementary PR-3 antigen.

Authors:  Jiajin Yang; David J Bautz; Sofia Lionaki; Susan L Hogan; Hyunsook Chin; Roland M Tisch; John L Schmitz; Barrak M Pressler; J Charles Jennette; Ronald J Falk; Gloria A Preston
Journal:  Kidney Int       Date:  2008-07-02       Impact factor: 10.612

Review 4.  Genetics of ANCA-associated Vasculitides.

Authors:  Manuel F Ugarte-Gil; Luis R Espinoza
Journal:  Curr Rheumatol Rep       Date:  2014-07       Impact factor: 4.592

5.  Two sisters with ANCA positive vasculitis.

Authors:  E A Murphy; R D Sturrock; J G Fox; J M Boulton-Jones
Journal:  Ann Rheum Dis       Date:  1993-05       Impact factor: 19.103

Review 6.  Granulomatosis with polyangiitis (Wegener's disease): An updated review of ocular disease manifestations.

Authors:  Buraa Kubaisi; Khawla Abu Samra; C Stephen Foster
Journal:  Intractable Rare Dis Res       Date:  2016-05

Review 7.  The contribution of genetic variation and infection to the pathogenesis of ANCA-associated systemic vasculitis.

Authors:  Lisa C Willcocks; Paul A Lyons; Andrew J Rees; Kenneth G C Smith
Journal:  Arthritis Res Ther       Date:  2010-02-15       Impact factor: 5.156

8.  Genetics of microscopic polyangiitis in the Japanese population.

Authors:  Naoyuki Tsuchiya
Journal:  Ann Vasc Dis       Date:  2012

9.  Cell-mediated autoimmunity in patients with Wegener's granulomatosis (WG)

Authors:  B E Ballieux; S H van der Burg; E C Hagen; F J van der Woude; C J Melief; M R Daha
Journal:  Clin Exp Immunol       Date:  1995-05       Impact factor: 4.330

Review 10.  Advances in the genomics of ANCA-associated vasculitis-a view from East Asia.

Authors:  Aya Kawasaki; Naoyuki Tsuchiya
Journal:  Genes Immun       Date:  2021-03-08       Impact factor: 2.676
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.